{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-163526","form_type":"8-K","ticker":"SVRA","cik":"0001160308","company_name":"Savara Inc","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.080214+00:00","generated_at":"2026-06-14T04:43:55.199976+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Savara updates corporate presentation; no material new disclosures","bullets":["Updated corporate presentation posted on IR page and furnished as Exhibit 99.1.","Presentation covers Savara's rare respiratory disease pipeline, no specific financial/operational updates provided.","No changes to guidance, pipeline status, or financial outlook disclosed in the filing.","Savara undertakes no obligation to update the presentation except through normal channels."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-163526","json":"https://secwatch.observer/filing/0001193125-23-163526.json","markdown":"https://secwatch.observer/filing/0001193125-23-163526.md","text":"https://secwatch.observer/filing/0001193125-23-163526.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1160308/000119312523163526/0001193125-23-163526-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1160308/000119312523163526/d518536d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:43:55.199976+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}